MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6506-1536-1542$20.00
Mol Pharmacol 65:1536-1542, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ren, X.-Q.
Right arrow Articles by Akiyama, S.-i.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ren, X.-Q.
Right arrow Articles by Akiyama, S.-i.

Function of the ABC Signature Sequences in the Human Multidrug Resistance Protein 1

Xiao-Qin Ren1, Tatsuhiko Furukawa, Misako Haraguchi, Tomoyuki Sumizawa, Shunji Aoki, Motomasa Kobayashi, and Shin-ichi Akiyama

Department of Molecular Oncology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan (X.-Q.R., T.F., M.H., T.S., S.Ak.); and Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan (S.Ao., M.K.)

Human multidrug resistance protein 1 (MRP1) is a membrane ATP-binding cassette transporter that confers multidrug resistance to tumor cells by effluxing intracellular drugs in an ATP-dependent manner. The mechanisms by which transport occurs and by which ATP hydrolysis is coupled to drug transport are not fully elucidated. In particular, the function of the signature sequences in the nucleotide binding domains (NBDs) of MRP1 is unknown. We therefore investigated the effect of mutation of the signature sequences (G771D and G1433D) and of the Walker A motifs (K684M and K1333M) in the NBDs on the 8-azido-[{alpha}-32P]ATP photolabeling and 8-azido-[{alpha}-32P]ADP vanadate trapping of MRP1. Both mutations in the Walker A motif almost completely inhibited the labeling of the mutated NBD with 8-azido-[{alpha}-32P]ATP but not the labeling of the other intact NBD. In contrast, the G771D mutation in the signature sequence of NBD1 enhanced the labeling of NBD1 but slightly decreased the labeling of NBD2. The G1433D mutation in the signature motif of NBD2 enhanced the labeling of NBD2 but did not affect the labeling of NBD1. These effects were all substrate-independent. Photolabeling of NBD2 and a very slight photolableing of NBD1 were detectable under vanadate trapping conditions with 8-azido-[{alpha}-32P]ATP. Trapping at both NBD1 and NBD2 was almost completely inhibited by K684M and K1333M mutations and by the K684M/K1333M double mutation. The G771D mutation completely inhibited trapping at NBD2 and considerably inhibited trapping at NBD1. However, whereas the G1433D mutation also considerably inhibited trapping at NBD1, it only partially inhibited trapping of NBD2, and the trapping could still be enhanced by leukotriene C4. Our findings suggest that both signature sequences of MRP1 are involved in ATP hydrolysis and must be intact for the ATP hydrolysis and the transport by MRP1.


Received November 10, 2003; accepted March 17, 2004

Address correspondence to: Dr. Shin-ichi Akiyama, Department of Molecular Oncology, Field of Oncology, Course of Advanced Therapeutics, Graduate School of Medical and Dental Sciences, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima 890-8520. E-mail: akiyamas{at}m3.kufm.kagoshima-u.ac.jp




This article has been cited by other articles:


Home page
JGPHome page
X. Wang, S. G. Bompadre, M. Li, and T.-C. Hwang
Mutations at the Signature Sequence of CFTR Create a Cd2+-gated Chloride Channel
J. Gen. Physiol., December 29, 2008; 133(1): 69 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Abla, L. W. Chinn, T. Nakamura, L. Liu, C. C. Huang, S. J. Johns, M. Kawamoto, D. Stryke, T. R. Taylor, T. E. Ferrin, et al.
The Human Multidrug Resistance Protein 4 (MRP4, ABCC4): Functional Analysis of a Highly Polymorphic Gene
J. Pharmacol. Exp. Ther., June 1, 2008; 325(3): 859 - 868.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T.-Y. Chen and T.-C. Hwang
CLC-0 and CFTR: Chloride Channels Evolved From Transporters
Physiol Rev, April 1, 2008; 88(2): 351 - 387.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
S. G. Bompadre, Y. Sohma, M. Li, and T.-C. Hwang
G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects
J. Gen. Physiol., March 26, 2007; 129(4): 285 - 298.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
X.-Q. Ren, T. Furukawa, M. Yamamoto, S. Aoki, M. Kobayashi, M. Nakagawa, and S.-i. Akiyama
A Functional Role of Intracellular Loops of Human Multidrug Resistance Protein 1
J. Biochem., September 1, 2006; 140(3): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev, July 1, 2006; 86(3): 849 - 899.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Nilius, J. Prenen, J. Tang, C. Wang, G. Owsianik, A. Janssens, T. Voets, and M. X. Zhu
Regulation of the Ca2+ Sensitivity of the Nonselective Cation Channel TRPM4
J. Biol. Chem., February 25, 2005; 280(8): 6423 - 6433.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Zhao and X.-b. Chang
Mutation of the Aromatic Amino Acid Interacting with Adenine Moiety of ATP to a Polar Residue Alters the Properties of Multidrug Resistance Protein 1
J. Biol. Chem., November 19, 2004; 279(47): 48505 - 48512.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Szentpetery, A. Kern, K. Liliom, B. Sarkadi, A. Varadi, and E. Bakos
The Role of the Conserved Glycines of ATP-binding Cassette Signature Motifs of MRP1 in the Communication between the Substrate-binding Site and the Catalytic Centers
J. Biol. Chem., October 1, 2004; 279(40): 41670 - 41678.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics